文献リスト

1) Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352: 1539-49

2) Cleland JG, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006; 27: 1928-32

3) McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007; 297: 2502-14

4) Kronborg MB, Mortensen PT, Kirkfeldt RE, et al. Very long term follow-up of cardiac resynchronization therapy: clinical outcome and predictors of mortality. Eur J Heart Fail. 2008; 10: 796-801

5) Zhang Q, Fung JW, Chan JY, et al. Difference in long-term clinical outcome after cardiac resynchronization therapy between ischemic and non-ischemic etiologies of heart failure. Heart. 2008. Epub ahead of print

6) Gasparini M, Regoli F, ceriotti C, et al. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors. Am Heart J. 2008; 155: 507-14

7) Sutton MG, Plappert T, Abraham WT, et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation. 2006; 113: 266-72

8) Castellant P, Fatemi M, Bertault-Valls V, et al. Cardiac resynchronization therapy: “nonresponders" and “hyperresponders". Heart Rhythm. 2008; 5: 193-7

9) Fujii B, Takami M. Normalization of left ventricular function following cardiac resynchronization therapy: left bundle branch block as a potential etiology of dilated cardiomyopathy. Circ J. 2008; 72: 1030-3

10) Yu CM, Bleeker GB, Fung JW, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005; 112: 1580-6

11) Bleeker GB, Mollema SA, Holman ER, et al. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation. 2007; 116: 1440-8

12) Di Biase L, Auricchio A, Sorgente A, et al. The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy. Eur Heart J. 2008; 29: 2497-505

13) Bleeker GB, Schalij MJ, Nihoyannopoulos P, et al. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol. 2005; 46: 2264-9

14) Yu CM, Fang F, Zhang Q, et al. Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure. J Am Coll Cardiol. 2007; 50: 778-85

15) Boerrigter G, Costello- Boerrigter LC, Abraham WT, et al. Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Card Fail. 2008; 14: 539-46

16) Kara T, Novak M, Nykodym J, et al. Short-term effects of cardiac resynchronization therapy on sleep-disordered breathing in patients with systolic heart failure. Chest. 2008; 134: 87-93

17) Chakir K, Daya SK, Tunin RS, et al. Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation. 2008; 117: 1369-77

18) Vanderheyden M, Vercauteren S, Mansour S, et al. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol. 2008; 51: 129-36

19) Vanderheyden M, Mullens W, Delrue L, et al. Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. J Card Fail. 2008; 14: 172-8

20) Lindenfeld J, Feldman AM, Saxon L, et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation. 2007; 115: 204-12

21) Cleland J, Freemantle N, Ghio S, et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol. 2008; 52: 438-45

22) Herweg B, Ilercil A, Cutro R, et al. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Am J Cardiol. 2007; 100: 90-3

23) Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art: cost versus benefit. Circulation. 2004; 109: 300-7

24) Konstantino Y, Iakobishvili Z, Arad O, et al. Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy. A case series. Cardiology. 2006; 106: 59-62

25) Anderson LJ, Miyazaki C, Sutherland GR, et al. Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy. Circulation. 2008; 117: 2009-23

26) Zamorano J, Perez de Isla L, Roque C, et al. The role of echocardiography in the assessment of mechanical dyssynchrony and its importance in predicting response to prognosis after cardiac resynchronization therapy. J Am Soc Echocardiogr. 2007; 20: 91-9

27) Chen J, Henneman MM, Trimble MA, et al. Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2008; 15: 127-36

28) Helm RH, Lardo AC. Cardiac magnetic resonance assessment of mechanical dyssynchrony. Curr Opin Cardiol. 2008; 23: 440-6

29) Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008; 117: 2608-16

30) Vesely MR, Li S, Kop WJ, et al. Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. Am J Cardiol. 2008; 101: 645-50

31) Suffoletto MS, Dohi K, Cannesson M, et al. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation. 2006; 113: 960-8

32) Miyazaki C, Powell BD, Bruce CJ, et al. Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left bundle-branch block. Circulation. 2008; 117: 2617-25

33) Lim P, Buakhamsri A, Popovic ZB, et al. Longitudinal strain delay index by speckle tracking imaging: a new marker of response to cardiac resynchronization therapy. Circulation. 2008; 118: 1130-7

34) Marsan NA, Bleeker GB, Ypenburg C, et al. Real-time three-dimensional echocardiography as a novel approach to assess left ventricular and left atrium reverse remodeling and to predict response to cardiac resynchronization therapy. Heart Rhythm. 2008; 5: 1257-64

35) Lafitte S, Bordachar P, Lafitte M, et al. Dynamic ventricular dyssynchrony: an exercise-echocardiography study. J Am Coll Cardiol. 2006; 47: 2253-9

36) Chattopdhyay S, Alamgir MF, Nikitin NP, et al. The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction. Eur J Heart Fail. 2008; 10: 412-20

37) Bleeker GB, Kaandorp TA, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006; 113: 969-76

38) White JA, Yee R, Yuan X, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol. 2006; 48: 1953-60

39) Riedlbauchova L, Brunken R, Jaber WA, et al. the impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2008. Epub ahead of print

40) Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007; 28: 2256-95

41) Macias A, Gavira J, Castano S, et al. Left ventricular pacing site in cardiac resynchronization therapy: clinical follow-up and predictors of failed lateral implant. Eur J Heart Fail. 2008; 10: 421-7

42) Ypenburg C, van Bommel RJ, Delgado V, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol. 2008; 52: 1402-9

43) D'Ivernois C, Lesage J, Blanc P, et al. Where are the left ventricular leads really implanted？ A study of 90 consecutive patients. Pacing Clin Electrophysiol. 2008; 31: 554-9

44) Van de Veire NR, Schuijf JD, De Sutter J, et al. Non-invasive visualization of the cardiac venous system in coronary artery disease patients using 64-slice computed tomography. J Am Coll Cardiol. 2006; 48: 1832-8

45) Burkhardt JD, Wilkoff BL. Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for heart failure. Circulation. 2007; 115: 2208-20

46) Leclercq C, Gadler F, Kranig W, et al. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J Am Coll Cardiol. 2008; 51: 1455-62

47) Yoshida K, Seo Y, Yamasaki H, et al. Effect of triangle ventricular pacing on haemodynamics and dyssynchrony in patients with advanced heart failure: a comparison study with conventional bi-ventricular pacing therapy. Eur Heart J. 2007; 28: 2610-9

48) Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008; 117: e350-408

49) Upadhyay GA, Choudhry NK, Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation. A meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2008; 52: 1239-46

50) Tolosana JM, Madrid AH, Brugada J, et al. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study). Am J Cardiol. 2008; 102: 444-9

51) Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrio-ventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2006; 48: 2243-50

52) Linde C, et al. Resynchronization reverses remodeling in systolic left ventricular dysfunction: Results of the REVERSE trial. ACC Meeting 2008; Abstract 412-3

53) Yu CM, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006, 48: 2251-7

54) Bleeker GB, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol. 2006; 48: 2243-50

55) JBeshai JF, Grimm RA, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007; 357: 2461-71

56) Bristow MR, Saxon LA, Boehner J, et al. Cardiac resynchronization therapy with or without implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350: 2140-50

57) Bai R, Biase LD, Elayi C, et al. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors. J Cardiovasc Electrophysiol. 2008; 19: 1259-65

58) Turitto G, El-Sherif N. Cardiac resynchronization therapy: a review of proarrhythmic and antiarrhythmic mechanisms. Pacing Clin Electrophysiol. 2007; 30: 115-22

59) Fish JM, Brugada J, Antzelevitch Cl. Potential proarrhythmic effects of biventricular pacing. J Am Coll Cardiol. 2005; 46: 2340-7

60) Kantharia BK, Patel JA, Nagra BS, et al. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade. Europace. 2006; 8: 625-8

61) Dhar R, Alsheikh-Ali AA, Estes NA 3rd, et al. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm. 2008; 5: 807-13

62) Ypenburg C, van Erven L, Bleeker GB, et al. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias. J Am Coll Cardiol. 2006; 48: 464-70

63) Saxon LA, Bristow MR, Boehmer J, et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006; 114: 2766-72

64) Nayak HM, Verdino RJ, Russo AM, et al. Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome. J Cardiovasc Electrophysiol. 2008; 19: 708-15

65) Piccini JP, Hernandez AF, Dai D, et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation. 2008; 118: 926-33

66) Amiya E, tanabe K, Ikari Y, et al. Prolonged QRS duration and severity of mitral regurgitation are unfavorable prognostic markers of heart failure in patients with nonischemic dilated cardiomyopathy. Circ J. 2006; 70: 57-62

67) Higuchi K, Toyama T, Tada H, et al. Usefulness of biventricular pacing to improve cardiac symptoms, exercise capacity and sympathetic nerve activity in patients with moderate to severe chronic heart failure. Circ J. 2006; 70: 703-9

68) Inage T, Yoshida T, Hiraki T, et al. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment. Europace. 2008; 10: 379-83

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp